Inter-center variations in length of hospitalization for infants with congenital jejunal or ileal atresia
- PMID: 41310308
- DOI: 10.1038/s41372-025-02481-0
Inter-center variations in length of hospitalization for infants with congenital jejunal or ileal atresia
Abstract
Objective: To quantify inter-center variation (ICV) in length of stay (LOS) among surviving infants with jejunal (JA) or ileal atresia (IA).
Study design: Children's Hospitals Neonatal Consortium's database was used to identify infants with JA or IA. After excluding infants with abdominal wall defects, survivors' hospital LOS was modeled as a function of center using generalized linear models with log link for gamma distribution.
Results: There were 1134 and 808 infants with JA and IA, respectively. LOS had significant ICV in unadjusted (JA: 5.4 [IQR 3.7,9.9] weeks; IA: 4.3 [IQR 2.4,11.4] weeks) and multivariable analyses (JA: 4+ fold difference (6.5-31.5 week); p < 0.001 IA: 8+ fold difference (1.7-14.6 weeks); p < 0.001) with modifiable risk factors including cholestasis, ostomy creation, blood stream infection, and residual bowel length <55 cm.
Conclusion: Risk-adjusted ICV in LOS was observed in infants with JA and IA, which exposes opportunities for improvements in outcomes for infants with intestinal atresia.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: Jae Kim is a consultant for Medela, Carag, Biomilq, Cardinal Health, Mother’s Milk is Best. Jae Kim has shares in Astate Medical, Nicolette, Cardinal Health. Jae Kim has sponsored research with Fresenius-Kabi. Michael Padula, Theresa Grover, and Karna Murthy are board members of CHNC. A portion of Theresa Grover’s and Karna Murthy’s faculty effort is supported by CHNC. Theresa Grover is present of CHNC. Funding: CHNC funded the analytic support for this project and supported a portion of Dr. Murthy’s faculty effort from 2023-2024 to complete this work. Ethics approval and consent to participate: Each individual CHNC site has received local ethical oversight for data entry into CHND, and the Stanley Manne Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago provided an exemption to analyze de-identified data from CHND (IRB#: 2011-14673). Informed consent has been waived for data entry into CHND. This study was performed in accordance with the Declaration of Helsinki.
References
-
- Kielt MJ, Zaniletti I, Lagatta JM, Padula MA, Grover TR, Porta NFM, et al. Liberation from Respiratory Support in Bronchopulmonary Dysplasia. J Pediatr. 2024;282:114390.
LinkOut - more resources
Full Text Sources
